Challenges and potential strategies utilizing external data for efficacy evaluation in small-sized clinical trials

Area of Science:

• Clinical Statistics
• Biopharmaceutical Development
• Drug Discovery

Background:

• Clinical trials for rare diseases often struggle with small patient populations, leading to recruitment difficulties.
• Challenges include insufficient statistical power, feasibility issues with randomization due to time and budget constraints, and ethical considerations.
• Efficiently developing breakthrough therapies requires innovative approaches to utilizing patient data.

Purpose of the Study:

• To address the challenges in developing clinical trials for diseases with very small patient populations.
• To present statistical methodologies that enhance the efficiency and feasibility of small-sized clinical trials.
• To highlight potential solutions for overcoming recruitment and design hurdles in rare disease drug development.

Main Methods:

• Discussion of Bayesian approaches for incorporating prior information.
• Exploration of the use of historical controls to reduce subject recruitment and ethical concerns.
• Examination of innovative study designs, such as platform designs, for improved trial efficiency.

Main Results:

• Identified key challenges in small-sized clinical trial development.
• Proposed statistical approaches to enhance power and feasibility.
• Demonstrated potential for Bayesian methods, historical controls, and platform designs.

Conclusions:

• Statistical innovations are crucial for overcoming limitations in small clinical trials.
• Bayesian approaches, historical controls, and platform designs offer promising solutions.
• These methods can accelerate the development of therapies for rare diseases.